ImmunoHorizon Issues Research Articles in Oct. 1, 2022 Edition
October 12, 2022
October 12, 2022
ROCKVILLE, Maryland, Oct. 12 -- ImmunoHorizon, a peer-reviewed journal from the American Association of Immunologists that says it focuses on immunology, published research articles on the following topics in its Oct. 1, 2022 edition:
CLINICAL AND TRANSLATIONAL IMMUNOLOGY:
* HIV-Specific CAR T Cells with CD28 or 4-1BB Signaling Domains Are Phenotypically and Functionally Distinct and Effective at Suppressing HIV and Simian Immunodeficiency Virus
INFECTIOUS . . .
CLINICAL AND TRANSLATIONAL IMMUNOLOGY:
* HIV-Specific CAR T Cells with CD28 or 4-1BB Signaling Domains Are Phenotypically and Functionally Distinct and Effective at Suppressing HIV and Simian Immunodeficiency Virus
INFECTIOUS . . .